1. 6H-Benzo[c]chromen-6-one derivatives as selective ERβ agonists
- Author
-
Milton L. Hammond, Elizabeth T. Birzin, Wanying Sun, Lovji D. Cama, Louis Locco, Ralph T. Mosley, Susan P. Rohrer, and Sudha Warrier
- Subjects
Agonist ,Molecular model ,Stereochemistry ,medicine.drug_class ,Fluoroimmunoassay ,Clinical Biochemistry ,Pharmaceutical Science ,Ligands ,Biochemistry ,Chemical synthesis ,Structure-Activity Relationship ,Drug Discovery ,Coactivator ,Benzene Derivatives ,Tumor Cells, Cultured ,polycyclic compounds ,medicine ,Estrogen Receptor beta ,Humans ,Structure–activity relationship ,Benzopyrans ,Molecular Biology ,chemistry.chemical_classification ,Molecular Structure ,Chemistry ,Organic Chemistry ,Estrogen Receptor alpha ,General Medicine ,Selective estrogen receptor modulator ,Molecular Medicine ,Selectivity ,hormones, hormone substitutes, and hormone antagonists ,Lactone - Abstract
A series of 6H-benzo[c]chromen-6-one and 6H-benzo[c]chromene derivatives were prepared, and the affinity and selectivity for ERalpha and ERbeta was measured. Many of the analogs were found to be potent and selective ERbeta agonists. Bis hydroxyl at positions 3 and 8 is essential for activity in a HTRF coactivator recruitment assay. Additional modifications at both phenyl rings led to compounds with ERbeta10nM potency and100-fold selectivity over ERalpha.
- Published
- 2006
- Full Text
- View/download PDF